BerGenBio
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol BGBIO:xosl
Currency NOK
Oslo Børs/Oslo Stock Exchange
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BerGenBio
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.0439339bn
Data Provided by 
/ 
/